David M. Frim, MD PhD
Affiliations: | Surgery, Section of Neurosurgery | University of Chicago Medical Center, Pritzker School of Medicine |
Area:
Hydrocephalus, NeurosurgeryGoogle:
"David Frim"Mean distance: 42746.4
Parents
Sign in to add mentorR. Michael Scott | grad student | Harvard - Boston Children's Hospital | ||
(Pediatric neurosurgery) | ||||
Nicholas Zervas | post-doc |
Children
Sign in to add traineeDaniel Curry | grad student | Baylor College of Medicine | |
Adam Frim | grad student | Berkeley, California | |
Lisa H. Merck | research scientist | Chicago |
Collaborators
Sign in to add collaboratorStephen B Tatter | collaborator | 1990-1995 | Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Madsen JR, Boyle TP, Neuman MI, et al. (2020) Diagnostic Accuracy of Non-Invasive Thermal Evaluation of Ventriculoperitoneal Shunt Flow in Shunt Malfunction: A Prospective, Multi-Site, Operator-Blinded Study. Neurosurgery |
Cadichon SB, Le Hoang M, Wright DA, et al. (2007) Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats. Journal of Neurosurgery. 106: 36-40 |
Curry DJ, Wright DA, Lee RC, et al. (2004) Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats. Journal of Neurosurgery. 101: 91-6 |
Curry DJ, Wright DA, Lee RC, et al. (2004) Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner. Neurosurgery. 55: 943-8; discussion 94 |
Frim DM, Wright DA, Curry DJ, et al. (2004) The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain. Neuroreport. 15: 171-4 |
Curry DJ, Wright DA, Lee RC, et al. (2003) Synthes Award for Resident Research in Brain and Craniofacial Injury: poloxamer 188 volumetrically decreases neuron loss in the rat model of excitotoxicity in a time-dependent manner. Clinical Neurosurgery. 50: 374-81 |
Frim DM, Scott RM. (1999) Management of cavernous malformations in the pediatric population. Neurosurgery Clinics of North America. 10: 513-8 |
Frim DM, Scott RM, Madsen JR. (1998) Surgical management of neonatal hydrocephalus. Neurosurgery Clinics of North America. 9: 105-10 |
Frim DM, Zec N, Golden J, et al. (1996) Immunohistochemically identifiable tissue plasminogen activator in cavernous angioma: mechanism for re-hemorrhage and lesion growth. Pediatric Neurosurgery. 25: 137-41; discussion 1 |
Galpern WR, Frim DM, Tatter SB, et al. (1996) Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplantation. 5: 225-32 |